Completed PHASE4 INTERVENTIONAL 3-arm NCT01937559

Topical Tranexamic Acid (TXA) in Joint Arthroplasty

Topical Application of Tranexamic Acid in Joint Arthroplasty

Sponsor: The Hawkins Foundation

Conditions Hip Arthropathy Osteoarthritis Shoulder Arthropathy

Interventions Normal saline Tranexamic acid (TXA)

Updated 8 times since 2017 Last updated: Apr 24, 2020 Started: Apr 30, 2013 Primary completion: Jun 30, 2018 Completion: Nov 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hip Arthropathy and Osteoarthritis and is currently completed. The Hawkins Foundation leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2020 — Jan 2021 [monthly]

Completed PHASE4
Feb 2019 — Jun 2020 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Hawkins Foundation

Data source: The Hawkins Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Greenville, United States